Plasma interleukin-8 levels are persistently elevated for 1 month after minimally invasive colorectal resection for colorectal cancer

Shantha Kumara,H. M.C.; Sutton,Elli; Bellini,Geoffrey  A.; Yan,Xiaohong; Rn,Vesna  Cekic; Gandhi,Nipa  Dilip; Whelan,Richard  L.

doi:10.3892/mco.2017.1538

March-2018 Volume 8 Issue 3

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

March-2018 Volume 8 Issue 3

Full Size Image

Article

Plasma interleukin-8 levels are persistently elevated for 1 month after minimally invasive colorectal resection for colorectal cancer

Authors:
- H. M.C. Shantha Kumara
- Elli Sutton
- Geoffrey A. Bellini
- Xiaohong Yan
- Vesna Cekic Rn
- Nipa Dilip Gandhi
- Richard L. Whelan
View Affiliations / Copyright

Affiliations: Division of Colon and Rectal Surgery, Department of Surgery, Mount Sinai West Hospital, New York, NY 10019, USA
Pages: 471-476
|
Published online on: December 18, 2017

https://doi.org/10.3892/mco.2017.1538
Expand metrics +

Abstract

Minimally invasive colorectal resection (MICR) for colorectal cancer (CRC) is associated with elevated levels of seven proangiogenic proteins that persist for 2‑4 weeks after surgery. The proangiogenic plasma may promote tumor growth postoperatively in patients with residual cancer. To the best of our knowledge, the impact of surgery on interleukin 8 (IL-8) levels is unknown. The aim of the present study was to evaluate plasma IL-8 levels after MICR for CRC. Patients with CRC enrolled in an institutional review board‑approved plasma/data bank who underwent MICR were eligible. Blood samples were taken preoperatively (preop) and at multiple postoperative (postop) time points, and were stored at ‑80˚C. Only patients for whom preop, postop day (POD) 1, POD 3 and at least 1 late postop plasma samples (POD7‑34) available were enrolled. Clinical, demographical and pathological data were collected. IL-8 levels were determined via ELISA and results were reported as the mean and ± standard deviation. The Wilcoxon signed rank test was used for analysis with P<0.05 used as the significance threshold. A total of 73 CRC patients (colon, 62%; rectal, 38%) who underwent MICR (laparoscopic‑assisted, 60%; hand‑assisted, 40%) were studied. The mean preop IL-8 level was 20.4±10.6 pg/ml. Significant elevations in plasma IL-8 levels were noted compared with preop levels on POD1 (43.1±38.6; n=72; P<0.0001), POD 3 (33.0±30.1; n=71; P<0.0001), POD7‑13 (29.9±21.9; n=50; P<0.0001), POD14‑20 (33.1±18.3; n=24; P=0.002), and for the POD21‑27 time point (24.0±9.2; n=16; P=0.002). In conclusion, plasma IL‑8 levels were significantly elevated from baseline for 4 weeks after MICR for CRC. In conjunction with the other proangiogenic MICR‑associated blood compositional changes, increased IL‑8 levels may promote tumor angiogenesis and growth postop.

View Figures

View References

1	Jagoditsch M, Lisborg PH, Jatzko GR, Wette V, Kropfitsch G, Denk H, Klimpfinger M and Stettner HM: Long-term prognosis for colon cancer related to consistent radical surgery: Multivariate analysis of clinical, surgical, and pathologic variables. World J Surg. 24:1264–1270. 2000. View Article : Google Scholar : PubMed/NCBI
2	Bird NC, Mangnall D and Majeed AW: Biology of colorectal liver metastases: A review. J Surg Oncol. 94:68–80. 2006. View Article : Google Scholar : PubMed/NCBI
3	Fisher B and Fisher ER: Experimental evidence in support of the dormant tumor cell. Science. 130:918–919. 1959. View Article : Google Scholar : PubMed/NCBI
4	Peeters CF, de Waal RM, Wobbes T, Westphal JR and Ruers TJ: Outgrowth of human liver metastases after resection of the primary colorectal tumor: A shift in the balance between apoptosis and proliferation. Int J Cancer. 119:1249–1253. 2006. View Article : Google Scholar : PubMed/NCBI
5	Eggermont AM, Steller EP, Marquet RL, Jeekel J and Sugarbaker PH: Local regional promotion of tumor growth after abdominal surgery is dominant over immunotherapy with interleukin-2 and lymphokine activated killer cells. Cancer Detect Prev. 12:421–429. 1988.PubMed/NCBI
6	Lee JW, Shahzad MM, Lin YG, Armaiz-Pena G, Mangala LS, Han HD, Kim HS, Nam EJ, Jennings NB, Halder J, et al: Surgical stress promotes tumor growth in ovarian carcinoma. Clin Cancer Res. 15:2695–2702. 2009. View Article : Google Scholar : PubMed/NCBI
7	Coffey JC, Wang JH, Smith MJ, Bouchier-Hayes D, Cotter TG and Redmond HP: Excisional surgery for cancer cure: Therapy at a cost. Lancet Oncol. 4:760–768. 2003. View Article : Google Scholar : PubMed/NCBI
8	O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH and Folkman J: Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 79:315–328. 1994. View Article : Google Scholar : PubMed/NCBI
9	Allendorf JD, Bessler M, Horvath KD, Marvin MR, Laird DA and Whelan RL: Increased tumor establishment and growth after open vs. laparoscopic surgery in mice may be related to differences in postoperative T-cell function. Surg Endosc. 13:233–235. 1999. View Article : Google Scholar : PubMed/NCBI
10	Peeters CF, de Geus LF, Westphal JR, de Waal RM, Ruiter DJ, Wobbes T, Oyen WJ and Ruers TJ: Decrease in circulating anti-angiogenic factors (angiostatin and endostatin) after surgical removal of primary colorectal carcinoma coincides with increased metabolic activity of liver metastases. Surgery. 137:246–249. 2005. View Article : Google Scholar : PubMed/NCBI
11	Belizon A, Balik E, Horst P, Feingold D, Arnell T, Azarani T, Cekic V, Skitt R, Kumara S and Whelan RL: Persistent elevation of plasma vascular endothelial growth factor levels during the first month after minimally invasive colorectal resection. Surg Endosc. 22:287–297. 2008. View Article : Google Scholar : PubMed/NCBI
12	Kumara HM, Feingold D, Kalady M, Dujovny N, Senagore A, Hyman N, Cekic V and Whelan RL: Colorectal resection is associated with persistent proangiogenic plasma protein changes: Postoperative plasma stimulates in vitro endothelial cell growth, migration, and invasion. Ann Surg. 249:973–977. 2009. View Article : Google Scholar : PubMed/NCBI
13	Kumara Shantha HM, Cabot JC, Yan X, Herath SA, Luchtefeld M, Kalady MF, Feingold DL, Baxter R and Whelan RL: Minimally invasive colon resection is associated with a persistent increase in plasma PlGF levels following cancer resection. Surg Endosc. 25:2153–2158. 2011. View Article : Google Scholar : PubMed/NCBI
14	Kumara Shantha HM, Tohme ST, Herath SA, Yan X, Senagore AJ, Nasar A, Kalady MF, Baxter R and Whelan RL: Plasma soluble vascular adhesion molecule-1 levels are persistently elevated during the first month after colorectal cancer resection. Surg Endosc. 26:1759–1764. 2012. View Article : Google Scholar : PubMed/NCBI
15	Kumara Shantha HM, Myers EA, Herath SA, Jang JH, Njoh L, Yan X, Kirchoff D, Cekic V, Luchtefeld M and Whelan RL: Plasma monocyte chemotactic protein-1 remains elevated after minimally invasive colorectal cancer resection. World J Gastrointest Oncol. 6:413–419. 2014. View Article : Google Scholar : PubMed/NCBI
16	Kumara Shantha HM, Gaita D, Miyagaki H, Yan X, Hearth SA, Njoh L, Cekic V and Whelan RL: Plasma chitinase 3-like 1 is persistently elevated during first month after minimally invasive colorectal cancer resection. World J Gastrointest Oncol. 8:607–614. 2016. View Article : Google Scholar : PubMed/NCBI
17	Kumara Shantha HM, Kirchoff D, Naffouje S, Grieco M, Herath SA, Dujovny N, Kalady MF, Hyman N, Njoh L and Whelan RL: Plasma from the second and third weeks after open colorectal resection for cancer stimulates in vitro endothelial cell growth, migration, and invasion. Surg Endosc. 26:790–795. 2012. View Article : Google Scholar : PubMed/NCBI
18	Li A, Varney ML, Valasek J, Godfrey M, Dave BJ and Singh RK: Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis. Angiogenesis. 8:63–71. 2005. View Article : Google Scholar : PubMed/NCBI
19	Srivastava SK, Bhardwaj A, Arora S, Tyagi N, Singh AP, Carter JE, Scammell JG, Fodstad Ø and Singh S: Interleukin-8 is a key mediator of FKBP51-induced melanoma growth, angiogenesis and metastasis. Br J Cancer. 112:1772–1781. 2015. View Article : Google Scholar : PubMed/NCBI
20	Lee YS, Choi I, Ning Y, Kim NY, Khatchadourian V, Yang D, Chung HK, Choi D, LaBonte MJ, Ladner RD, et al: Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis. Br J Cancer. 106:1833–1841. 2012. View Article : Google Scholar : PubMed/NCBI
21	Brew R, Erikson JS, West DC, Flanagan BF and Christmas SE: Interleukin-8 as a growth factor for human colorectal carcinoma cells in vitro. Biochem Soc Trans. 25:264S1997. View Article : Google Scholar : PubMed/NCBI
22	Mian BM, Dinney CP, Bermejo CE, Sweeney P, Tellez C, Yang XD, Gudas JM, McConkey DJ and Bar-Eli M: Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB. Clin Cancer Res. 9:3167–3175. 2003.PubMed/NCBI
23	Yao C, Lin Y, Chua MS, Ye CS, Bi J, Li W, Zhu YF and Wang SM: Interleukin-8 modulates growth and invasiveness of estrogen receptor-negative breast cancer cells. Int J Cancer. 121:1949–1957. 2007. View Article : Google Scholar : PubMed/NCBI
24	Brat DJ, Bellail AC and Van Meir EG: The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro-Oncol. 7:122–133. 2005. View Article : Google Scholar : PubMed/NCBI
25	Araki S, Omori Y, Lyn D, Singh RK, Meinbach DM, Sandman Y, Lokeshwar VB and Lokeshwar BL: Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer. Cancer Res. 67:6854–6862. 2007. View Article : Google Scholar : PubMed/NCBI
26	Jiang WG, Sanders AJ, Ruge F and Harding KG: Influence of interleukin-8 (IL-8) and IL-8 receptors on the migration of human keratinocytes, the role of PLC-γ and potential clinical implications. Exp Ther Med. 3:231–236. 2012. View Article : Google Scholar : PubMed/NCBI
27	Sticherling M, Bornscheuer E, Schröder JM and Christophers E: Localization of neutrophil-activating peptide-1/interleukin-8-immunoreactivity in normal and psoriatic skin. J Invest Dermatol. 96:26–30. 1991. View Article : Google Scholar : PubMed/NCBI
28	Kumara Shantha HM, Tohme ST, Kim IY, Kim DG, Kalady MF, Luchtefeld M, Hoffman K, Dimaggio V and Whelan RL: Minimally invasive colorectal resection is associated with a transient increase in plasma hepatocyte growth factor levels early after surgery for colon cancer. Surg Innov. 18:254–258. 2011. View Article : Google Scholar : PubMed/NCBI
29	Harmon GD, Senagore AJ, Kilbride MJ and Warzynski MJ: Interleukin-6 response to laparoscopic and open colectomy. Dis Colon Rectum. 37:754–759. 1994. View Article : Google Scholar : PubMed/NCBI
30	Ordemann J, Jacobi CA, Schwenk W, Stösslein R and Müller JM: Cellular and humoral inflammatory response after laparoscopic and conventional colorectal resections. Surg Endosc. 15:600–608. 2001. View Article : Google Scholar : PubMed/NCBI
31	Li A, Dubey S, Varney ML, Dave BJ and Singh RK: IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol. 170:3369–3376. 2003. View Article : Google Scholar : PubMed/NCBI
32	Mizukami Y, Jo WS, Duerr EM, Gala M, Li J, Zhang X, Zimmer MA, Iliopoulos O, Zukerberg LR, Kohgo Y, et al: Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells. Nat Med. 11:992–997. 2005. View Article : Google Scholar : PubMed/NCBI
33	Karayiannakis AJ, Zbar A, Polychronidis A and Simopoulos C: Serum and drainage fluid vascular endothelial growth factor levels in early surgical wounds. Eur Surg Res. 35:492–496. 2003. View Article : Google Scholar : PubMed/NCBI
34	Wu FP, Hoekman K, Meijer S and Cuesta MA: VEGF and endostatin levels in wound fluid and plasma after breast surgery. Angiogenesis. 6:255–257. 2003. View Article : Google Scholar : PubMed/NCBI
35	Wu FP, Hoekman K, Sietses C, von Blomberg BM, Meijer S, Bonjer HJ and Cuesta MA: Systemic and peritoneal angiogenic response after laparoscopic or conventional colon resection in cancer patients: A prospective, randomized trial. Dis Colon Rectum. 47:1670–1674. 2004. View Article : Google Scholar : PubMed/NCBI
36	Peeters CF, Westphal JR, de Waal RM, Ruiter DJ, Wobbes T and Ruers TJ: Vascular density in colorectal liver metastases increases after removal of the primary tumor in human cancer patients. Int J Cancer. 112:554–559. 2004. View Article : Google Scholar : PubMed/NCBI
37	Scheer MG, Stollman TH, Vogel WV, Boerman OC, Oyen WJ and Ruers TJ: Increased metabolic activity of indolent liver metastases after resection of a primary colorectal tumor. J Nucl Med. 49:887–891. 2008. View Article : Google Scholar : PubMed/NCBI